Bristol-Myers Squibb Co. (BMY) PT Raised to $60 at Citi
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $64.63 +1.25%
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Citi analyst Geoff Meacham raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $60.00 (from $53.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Guggenheim Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
- York Space Systems (YSS) PT Lowered to $15 at Jefferies
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
